Scientists find the key to preventing, treating severe COVID-19
Scientists from The Ohio State University found that blocking an immune response-related enzyme holds promise in preventing or treating severe COVID-19 symptoms by reducing...
First head-to-head comparison of four COVID-19 vaccines
Scientists from La Jolla Institute for Immunology reported the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2.
Their...
Why some people physically less likely to get COVID-19
In a recent study from AncestryDNA, researchers found three newly-defined phenotypes (observable characteristics or traits for an individual) that capture genetic associations which may...
This is the best way to test COVID-19, study finds
Scientists from Cornell University found that nasopharyngeal swabs—taken from far back inside the nostril—were more effective at detecting COVID-19 than saliva tests or swabs...
These people have best COVID-19 protection, study finds
In a recent study from the Federal University of Mato Grosso do Sul, researchers found that people with the “hybrid immunity” of having been...
People who get COVID-19 could have antibodies for 500 days
Scientists from the University of Texas found that adults who get COVID-19 could have antibodies circulating in their blood for nearly 500 days after...
Breakthrough COVID infections more likely in these people
Scientists from Case Western Reserve University found that breakthrough COVID-19 cases resulting in infections, hospitalizations and deaths are much more likely in cancer and...
End of strict COVID measures in China could result in 1.5 million deaths in...
In a new study published in Nature Medicine, researchers revealed that if China rescinds Zero-COVID policies, the country’s healthcare system will almost certainly be...
Kidney injury from COVID-19 may be twice as common as diagnosed
Scientists from the University of Queensland found millions of COVID-19 patients may have undiagnosed acute kidney injury (AKI).
The research is published in PLOS Medicine...
Vaccines have up to 90% efficacy against severe COVID-19 for up to 6 months
Scientists from Penn State found that protection against symptomatic COVID-19 begins to decrease after one month from initial vaccination, while immunity against severe COVID-19...